medigraphic.com
SPANISH

Archivos de Cardiología de México

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2004, Number s2

<< Back Next >>

Arch Cardiol Mex 2004; 74 (s2)

Integral evaluation of mitral valvulopathy as a guide for its treatment

Malpartida TF, Vivancos DR, Fernández Madero G
Full text How to cite this article

Language: Spanish
References: 11
Page: 312-315
PDF size: 52.97 Kb.


Key words:

Mitral stenosis, Mitral incompetence, Percutaneous mitral Valvulotomy, Mitral valve repair.

ABSTRACT

Knowledge of the natural history of mitral valve disease means that patients who are asymptomatic, or minimally symptomatic, can undergo surgery to improve their prognosis. Accordingly, a full history and physical examination should be performed to determine the functional status, as well as chest radiography and an electrocardiogram to complete the initial evaluation before deciding on treatment. Echocardiography is the most important non-invasive technique for evaluating the hemodynamic repercussions and valve anatomy. Evaluation of mitral valve stenosis should include the mean gradient, valve area and, most importantly, a detailed study of the valve morphology, to select the best possible candidates for surgery, which is percutaneous mitral valvulotomy. Follow-up over 8 years of 220 patients after percutaneous mitral valvulotomy showed that adverse events were related with an age › 56 years, the presence of atrial fibrillation and an echocardiographic score › 9. Evaluation of mitral incompetence should include symptomatic repercussions, as the possibility of repair exists in barely symptomatic patients, to prevent left ventricular dysfunction, which is the main factor influencing prognosis. An almost perfect repair requires prior selection of patients with an echocardiographic study, which enables recognition of the etiology and mechanism of the mitral incompetence and posterior control with intraoperative transesophageal echocardiography. In our experience, as in that of many others, it is more feasible to repair prolapse of the posterior valve (100% of our cases) than the anterior valve (25% of our cases).


REFERENCES

  1. Bonow RO, Carabello B, de León AC Jr, Edmunds LH Jr, Fredderly BJ, Freed MD, et al: ACC/AHA guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (Commitee on management of patients with valvular heart disease). J Am Coll Cardiol 1998; 32: 1486-1588.

  2. Azpitarte J, Alonso AM, García Gallego F, González Santos JM, Paré C, Tello A: Guías de práctica clínica de la Sociedad Española de Cardiología en valvulopatías. Rev Esp Cardiol 2000; 53: 1209-1278.

  3. Wilkins GT, Weyman AE, Abascal VM, Block PC, Palacios IE: Percutaneous balloon dilatation of the mitral valve. An analysis of echocardiographics variables related to outcome and the mechanism of dilatation. Br Heart J 1988; 60: 299-308.

  4. Hernández García JM, Castillo Castro JL, Alonso Briales JH, Álvarez de Cienfuegos Rivera F, Bullones Ramírez J, Álvarez Rubiera J, et al: Seguimiento actuarial tras valvuloplastía mitral percutánea. Incidencia y factores predictores de eventos. Rev Esp Cardiol 1999; 52: 503-511.

  5. Fernández-Madero G, González-Cabezón JL, Álvarez J, Vivancos R, Zafra J, Ríos C, et al: Gradiente mitral medio basal y tras esfuerzo en la valoración de la Estenosis mitral. Sensibilidad y especificidad. Rev Soc Andal Cardiol 1998: 30: 95-102.

  6. Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Bärwolf Ch, Levang OW, et al: A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003; 24: 1231-1243.

  7. Dujardin KS, Seward JB, Orszulak TA, Schaff HV, Bailey KR, Tajik AJ, et al: Outcome after surgery for mitral regurgitation. Determinants of postoperative morbility and mortality. J Heart Valve Dis 1997:6:17-21.

  8. Thomas L, Foster E, Hoffman JI, Schiller NB: Prospective validation of an echocardiographic index for determining the severity of chronic mitral regurgitation. Am J Cardiol 2002; 90: 607-622.

  9. Enriquez Sarano M: Timing of mitral valve surgery. Heart 2000; 87: 79-85.

  10. Carretero JF, Vivancos R, Mora J, de Mora M, Sánchez Calle JM, Cuenca V, et al: Criterios ecocardiográficos de selección de pacientes para reparación valvular mitral. Rev Esp Cardiol 2001; 54 (Supl 2): 69.

  11. Mora J, Vivancos R, Carretero JF, de Mora M, Sánchez Calle JM, Cuenca V, et al: Resultados a corto y medio plazo de la cirugía de reparación mitral guiada por ecocardiografía transesofágica. Rev Esp Cardiol 2001; 54 (Supl 2): 164.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Arch Cardiol Mex. 2004;74